• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    7/18/24 1:19:11 PM ET
    $ACXP
    $ADTX
    $AGEN
    $ALK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACXP alert in real time by email

    Shares of Domino’s Pizza, Inc. (NYSE:DPZ) fell sharply during Thursday's session after the company reported mixed quarterly results.

    The company reported second-quarter FY24 sales growth of 7.1% year-on-year to $1.097 billion, missing the analyst consensus estimate of $1.103 billion.

    The company is temporarily suspending its guidance metric of 1,100+ global net stores growth until the full effect of DPE's store opens and closures on international net store growth are known.

    Domino’s Pizza shares dipped 11.2% to $420.36 on Thursday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Onconetix, Inc. (NASDAQ:ONCO) climbed 97.6% to $0.2944. On July 15, Onconetix announced closing of warrant exercise for $1.11 million gross proceeds.
    • Silo Pharma, Inc. (NASDAQ:SILO) jumped 71.6% to $3.86. Silo Pharma said it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider.
    • Chuy’s Holdings, Inc. (NASDAQ:CHUY) rose 47.6% to $37.29 after the company and Darden Restaurants, Inc. (NYSE:DRI) jointly announced that Darden will acquire Chuy's Holdings.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) jumped 24.8% to $0.8873.
    • CommScope Holding Company, Inc. (NASDAQ:COMM) gained 19% to $2.0407. Amphenol announced plans to acquire mobile networks businesses from CommScope.
    • LivePerson, Inc. (NASDAQ:LPSN) gained 18% to $1.1500. LivePerson is expected to release its second quarter financial results after the closing bell on Wednesday, July 31.
    • Kopin Corporation (NASDAQ:KOPN) rose 16% to $1.32. Kopin said it has achieved production approval milestone on next generation F-35 OLEDoS Microdisplay.
    • NKGen Biotech, Inc. (NASDAQ:NKGN) surged 15.3% to $1.08 after the company announced it will present new SNK01 biomarker data at the Alzheimer’s Association International Conference.
    • ZimVie Inc. (NASDAQ:ZIMV) gained 14.7% to $21.74.
    • Virtu Financial, Inc. (NASDAQ:VIRT) rose 13.2% to $26.61 after the company reported better-than-expected second-quarter financial results.
    • Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) rose 10.7% to $2.90.
    • D.R. Horton, Inc. (NYSE:DHI) shares rose 10.6% to $174.29 after the company reported better-than-expected third-quarter financial results and revised its FY24 guidance. Also, the company authorized a new $4 billion share repurchase.
    • Canadian Solar Inc. (NASDAQ:CSIQ) gained 8.3% to $17.89.
    • Infosys Limited (NYSE:INFY) rose 7.4% to $22.07 as the company reported first-quarter revenue growth of 2.5% in constant currency terms year-on-year to $4.71 billion, beating the analyst consensus estimate of $4.65 billion.
    • Ostin Technology Group Co Ltd (NASDAQ:OST) shares climbed 7.1% to $0.2944.
    • Toll Brothers, Inc. (NYSE:TOL) gained 6% to $135.83 in sympathy with D.R. Horton, which reported better-than-expected third-quarter financial results.

    Losers

    • Agenus Inc. (NASDAQ:AGEN) shares fell 52.7% to $8.36 after the company announced the FDA discouraged an accelerated approval pathway at the end-of-Phase 2 meeting.
    • Leslie’s, Inc. (NASDAQ:LESL) fell 30.7% to $2.83 after the company reported preliminary financial results for the third quarter and cut its full-year guidance. Multiple analysts also lowered price targets on the stock Thursday morning.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) fell 26% to $4.57. Alaunos Therapeutics announced a reverse stock split of 1-for-10, effective July 18.
    • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares fell 23% to $0.4471 after jumping 76% on Wednesday. On July 1, Aptevo Therapeutics announced the closing of $2.75 million offering.
    • Aditxt, Inc. (NASDAQ:ADTX) shares fell 19.7% to $1.86. Aditxt shares climbed around 46% on Wednesday after the company and Evofem amended and restated their merger agreement.
    • Locafy Limited (NASDAQ:LCFY) fell 19% to $5.33.
    • SunPower Corporation (NASDAQ:SPWR) fell 17.2% to $2.0850.
    • Torrid Holdings Inc. (NYSE:CURV) fell 16.7% to $7.16 after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and maintained its $5 price target.
    • Longeveron Inc. (NASDAQ:LGVN) declined 16.6% to $3.25. Longeveron announced a $9.0 million registered direct offering priced at-the-market under Nasdaq rules.
    • Forestar Group Inc. (NYSE:FOR) fell 13.9% to $30.99 after the company reported worse-than-expected third-quarter EPS and revenues.
    • Stardust Power Inc. (NASDAQ:SDST) shares declined 13.3% to $21.22 after jumping around 145% on Wednesday.
    • Cetus Capital Acquisition Corp. (NASDAQ:CETU) shares declined 13.2% to $8.60 after surging 80% on Wednesday.
    • Meiwu Technology Company Limited (NASDAQ:WNW) fell 13.2% to $1.11 after jumping more than 40% on Wednesday.
    • Fitell Corporation (NASDAQ:FTEL) fell 12% to $23.55.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) shares fell 12% to $0.80 after jumping around 32% on Wednesday.
    • Beyond Meat, Inc. (NASDAQ:BYND) shares fell 9.4% to $6.49 following a report suggesting the company’s liquidity has weakened and it is engaging bondholders for debt discussions.
    • 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) declined 8.1% to $16.73. The company announced the presentation of Phase 2 PRISM interim data.
    • Texas Capital Bancshares, Inc. (NASDAQ:TCBI) fell 6.2% to $66.17 following downbeat quarterly results.
    • Nokia Oyj (NYSE:NOK) fell 5.9% to $3.66 after the company reported mixed quarterly financial results.
    • Alaska Air Group, Inc. (NYSE:ALK) declined 5.4% to $37.85 as the company reported second-quarter 2024 total operating revenue growth of 2% year-over-year to $2.897 billion, missing the consensus of $2.945 billion.

    Now Read This:

    • PodcastOne And 2 Other Stocks Under $2 Insiders Are Buying
    Get the next $ACXP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACXP
    $ADTX
    $AGEN
    $ALK

    CompanyDatePrice TargetRatingAnalyst
    Forestar Group Inc
    $FOR
    3/30/2026Neutral
    BTIG Research
    Nokia Corporation Sponsored
    $NOK
    3/30/2026Sell → Neutral
    Goldman
    Alaska Air Group Inc.
    $ALK
    3/24/2026$50.00Outperform
    BMO Capital Markets
    Canadian Solar Inc.
    $CSIQ
    3/17/2026$19.00Underperform → Neutral
    Mizuho
    Nokia Corporation Sponsored
    $NOK
    3/13/2026Buy → Neutral
    Arete
    Toll Brothers Inc.
    $TOL
    3/4/2026$190.00Buy
    Truist
    D.R. Horton Inc.
    $DHI
    3/4/2026$155.00Hold
    Truist
    Domino's Pizza Inc
    $DPZ
    2/24/2026$450.00Neutral → Overweight
    Analyst
    More analyst ratings

    $ACXP
    $ADTX
    $AGEN
    $ALK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Arbour Paola M bought $91,500 worth of shares (1,000 units at $91.50), increasing direct ownership by 18% to 6,671 units (SEC Form 4)

    4 - TEXAS CAPITAL BANCSHARES INC/TX (0001077428) (Issuer)

    3/12/26 5:27:13 PM ET
    $TCBI
    Major Banks
    Finance

    Director Stallings Robert W bought $579,200 worth of Depositary Shares for Series B Preferred Stock (25,500 units at $22.71), increasing direct ownership by 17% to 175,087 units (SEC Form 4)

    4 - TEXAS CAPITAL BANCSHARES INC/TX (0001077428) (Issuer)

    3/9/26 4:06:40 PM ET
    $TCBI
    Major Banks
    Finance

    Director Stallings Robert W bought $1,000,950 worth of Depositary Shares for Series B Preferred Stock (45,000 units at $22.24), increasing direct ownership by 43% to 149,587 units (SEC Form 4)

    4 - TEXAS CAPITAL BANCSHARES INC/TX (0001077428) (Issuer)

    3/5/26 4:05:12 PM ET
    $TCBI
    Major Banks
    Finance

    $ACXP
    $ADTX
    $AGEN
    $ALK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026

    Study highlights novel multi-mechanistic immunotherapy combination in checkpoint-refractory disease Data expected to inform immune modulation, treatment sequencing, and durability of response across hard-to-treat tumors Agenus Inc. (NASDAQ:AGEN), a leader in immuno-oncology innovation, today announced that data from an investigator-initiated Phase II trial conducted at Memorial Sloan Kettering Cancer Center will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 17–22, 2026, in San Diego, CA. The study evaluates botensilimab (BOT) and balstilimab (BAL) in combination with agenT-797, an allogeneic iNKT cell therapy developed by MiN

    4/3/26 7:30:00 AM ET
    $AGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Toll Brothers Announces New Luxury Townhome Community Coming Soon to Charlotte, North Carolina

    CHARLOTTE, N.C., April 02, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest community, Toll Brothers at South Park, is coming soon to Charlotte, North Carolina. This stylish townhome community will feature thoughtfully designed floor plans in a desirable location just minutes from SouthPark Mall and Uptown Charlotte. Site work is underway, and the community is anticipated to open for sale in late 2026. Located in a vibrant neighborhood brimming with upscale shopping and dining, Toll Brothers at South Park will feature elegant townhomes offering over 2,000 square feet of bright open-concept living space, pri

    4/2/26 2:57:45 PM ET
    $TOL
    Homebuilding
    Consumer Discretionary

    Toll Brothers Honored at the New Jersey Builders Association Awards

    FREEHOLD, N.J., April 02, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the Company's New Jersey division was recently honored with 10 awards at the Sales and Marketing Awards (SAM) ceremony presented by the New Jersey Builders Association held recently at the Hard Rock Hotel and Casino in Atlantic City, New Jersey. Two Toll Brothers communities in New Jersey were honored with the coveted "Community of the Year" award: Canter Square in Manalapan and Regency at Cranbury in Cranbury. The Toll Brothers Design Studio in Dayton was also honored with the Best Design Center award. Presented by the New Jersey Builders Ass

    4/2/26 2:57:07 PM ET
    $TOL
    Homebuilding
    Consumer Discretionary

    $ACXP
    $ADTX
    $AGEN
    $ALK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research resumed coverage on Forestar

    BTIG Research resumed coverage of Forestar with a rating of Neutral

    3/30/26 8:18:40 AM ET
    $FOR
    Real Estate
    Finance

    Nokia upgraded by Goldman

    Goldman upgraded Nokia from Sell to Neutral

    3/30/26 8:13:23 AM ET
    $NOK
    Radio And Television Broadcasting And Communications Equipment
    Technology

    BMO Capital Markets initiated coverage on Alaska Air with a new price target

    BMO Capital Markets initiated coverage of Alaska Air with a rating of Outperform and set a new price target of $50.00

    3/24/26 8:29:28 AM ET
    $ALK
    Air Freight/Delivery Services
    Consumer Discretionary

    $ACXP
    $ADTX
    $AGEN
    $ALK
    SEC Filings

    View All

    SEC Form DEF 14A filed by Aditxt Inc.

    DEF 14A - Aditxt, Inc. (0001726711) (Filer)

    4/3/26 4:37:32 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-1 filed by American Rebel Holdings Inc.

    S-1 - AMERICAN REBEL HOLDINGS INC (0001648087) (Filer)

    4/3/26 4:06:38 PM ET
    $AREB
    Plastic Products
    Industrials

    Torrid Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Torrid Holdings Inc. (0001792781) (Filer)

    4/3/26 4:01:20 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ACXP
    $ADTX
    $AGEN
    $ALK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Lehr Paul T

    4 - Longeveron Inc. (0001721484) (Issuer)

    4/3/26 5:00:18 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Locklear Lisa

    4 - Longeveron Inc. (0001721484) (Issuer)

    4/3/26 5:00:15 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Blass Devin

    4 - Longeveron Inc. (0001721484) (Issuer)

    4/3/26 5:00:12 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACXP
    $ADTX
    $AGEN
    $ALK
    Leadership Updates

    Live Leadership Updates

    View All

    Toll Brothers Announces New Luxury Townhome Community Coming Soon to Charlotte, North Carolina

    CHARLOTTE, N.C., April 02, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest community, Toll Brothers at South Park, is coming soon to Charlotte, North Carolina. This stylish townhome community will feature thoughtfully designed floor plans in a desirable location just minutes from SouthPark Mall and Uptown Charlotte. Site work is underway, and the community is anticipated to open for sale in late 2026. Located in a vibrant neighborhood brimming with upscale shopping and dining, Toll Brothers at South Park will feature elegant townhomes offering over 2,000 square feet of bright open-concept living space, pri

    4/2/26 2:57:45 PM ET
    $TOL
    Homebuilding
    Consumer Discretionary

    Toll Brothers Announces New Luxury Condominium Community Coming Soon to Scottsdale, Arizona

    SCOTTSDALE, Ariz., April 01, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest luxury condominium community, Toll Brothers at Cavasson, is coming soon to Scottsdale, Arizona. Nestled within a vibrant new development, this gated community will showcase stunning three-story condos starting from the upper $900,000s, offering home shoppers modern, open-concept living in an exceptional location. The community is expected to open for sale in late 2026. Toll Brothers at Cavasson will feature spacious floor plans ranging from 1,965 to 2,672 square feet, with 2 to 4 bedrooms, two- and three-car garages, and private r

    4/1/26 2:01:20 PM ET
    $TOL
    Homebuilding
    Consumer Discretionary

    Toll Brothers Announces New Luxury Waterfront Community Coming Soon to Marion, Massachusetts

    MARION, Mass., April 01, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest luxury waterfront community,  Marion Pointe by Toll Brothers, is coming soon to Marion, Massachusetts. This exclusive neighborhood will feature modern home designs, upscale amenities, and a serene seaside location. Site work is underway at 78 Wareham Road in Marion, and the community is anticipated to open for sale in late summer 2026. Marion Pointe by Toll Brothers will offer an array of home designs featuring open-concept floor plans, first-floor primary bedroom suites, stunning outdoor living options, and up to 2,759 square feet of

    4/1/26 1:50:19 PM ET
    $TOL
    Homebuilding
    Consumer Discretionary

    $ACXP
    $ADTX
    $AGEN
    $ALK
    Financials

    Live finance-specific insights

    View All

    Alaska Air Group announces webcast of first quarter 2026 financial results

    SEATTLE, March 31, 2026 /PRNewswire/ -- Alaska Air Group Inc., the parent company of Alaska Airlines Inc., Hawaiian Airlines, Inc. and Horizon Air Industries Inc., will hold its quarterly conference call to discuss 2026 first quarter financial results at 11:30 a.m. EDT/ 8:30 a.m. PDT, Tuesday, April 21, 2026. A webcast of the call will be available to the public at www.alaskaair.com/investors. An archive of the call will be posted on the website later that morning. The company will file its first quarter results and outlook after market close on Monday, April 20, 2026.About Alas

    3/31/26 6:40:00 PM ET
    $ALK
    Air Freight/Delivery Services
    Consumer Discretionary

    Beyond Meat® Reports Fourth Quarter and Full Year 2025 Financial Results

    Company enters 2026 with reduced leverage, extended debt maturity and added liquidity Pursues top-line stabilization and margin expansion with strategic brand repositioning to Beyond The Plant Protein Company™ EL SEGUNDO, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ:BYND), otherwise known as Beyond The Plant Protein Company™ (the "Company"), today reported financial results for its fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights1 Net revenues were $61.6 million, a decrease of 19.7% year-over-year.Gross profit was $1.4 million, or gross margin of 2.3%, compared to gross profit of $10.0 million, or gross margin of 13.

    3/31/26 5:01:38 PM ET
    $BYND
    Packaged Foods
    Consumer Staples

    Kopin Corporation Reports Fourth Quarter 2025 Financial Results

    Balance Sheet Strengthened with $56 Million Capital Raise; Strategic Partnerships Advancing Key Defense Projects; Government Shutdown Delayed Revenue Recognition on Select Orders Industrywide Kopin Corporation (NASDAQ:KOPN) ("Kopin" or the "Company"), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced preliminary unaudited financial results for its fourth quarter ended December 27, 2025. Fourth Quarter Financial Summary: $ in millions Q4 2025 Q4 2024 % Change Total Revenues $8.4 $14.6 (42%) Produc

    3/27/26 8:00:00 AM ET
    $KOPN
    Semiconductors
    Technology

    $ACXP
    $ADTX
    $AGEN
    $ALK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by JE Cleantech Holdings Limited

    SC 13D/A - JE Cleantech Holdings Ltd (0001905511) (Subject)

    11/25/24 6:13:31 AM ET
    $JCSE
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by 4D Molecular Therapeutics Inc.

    SC 13G/A - 4D Molecular Therapeutics, Inc. (0001650648) (Subject)

    11/15/24 5:05:27 PM ET
    $FDMT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care